Gene · 23049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome driven discovery of novel candidate genes for human neurological disorders in the telomer-to-telomer genome assembly era. | Hum Genomics | 2023 | 37872607 | PubTator, text mining | PubMed |
| Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37868779 | PubTator, text mining | PubMed |
| Optimising Wastewater Treatment: Acinetobacter sp. IrC1 as a potential multi-resistant bacterium for copper accumulation and dyes decolourisation. | Trop Life Sci Res | 2023 | 37860091 | PubTator, text mining | PubMed |
| ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry. | Chin Med J (Engl) | 2023 | 37858319 | PubTator, text mining | PubMed |
| The Role of Inflammation in Cholestatic Liver Injury. | J Inflamm Res | 2023 | 37854312 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Circular RNA CCT3 is a unique molecular marker in bladder cancer. | BMC Cancer | 2023 | 37833621 | PubTator, text mining | PubMed |
| Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I study. | Signal Transduct Target Ther | 2023 | 37828033 | PubTator, text mining | PubMed |
| Altered expression of proteins involved in metabolism in LGMDR1 muscle is lost in cell culture conditions. | Orphanet J Rare Dis | 2023 | 37817200 | PubTator, text mining | PubMed |
| Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA-AF. | J Am Heart Assoc | 2023 | 37815118 | PubTator, text mining | PubMed |
| Mathematical model of aging in COVID-19. | J Med Biochem | 2023 | 37814624 | PubTator, text mining | PubMed |
| YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner. | Nat Commun | 2023 | 37803021 | PubTator, text mining | PubMed |
| A longitudinal multi-site evaluation of community-based partnerships: implications for researchers, funders, and communities. | Health Res Policy Syst | 2023 | 37789349 | PubTator, text mining | PubMed |
| Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis. | Sci Rep | 2023 | 37777564 | PubTator, text mining | PubMed |
| Emerging roles of ferroptosis in male reproductive diseases. | Cell Death Discov | 2023 | 37770442 | PubTator, text mining | PubMed |
| Targeting phosphoglycerate kinases by tatridin A, a natural sesquiterpenoid endowed with anti-cancer activity, using a proteomic platform. | Front Mol Biosci | 2023 | 37767160 | PubTator, text mining | PubMed |
| The Protective Effects of Moisturizer Containing Potentilla anserina Extract in the Topical Treatment of Skin Damage Caused by Masks. | Int J Mol Sci | 2023 | 37762597 | PubTator, text mining | PubMed |
| Lipid-Based Nanocarriers for Delivery of Neuroprotective Kynurenic Acid: Preparation, Characterization, and BBB Transport. | Int J Mol Sci | 2023 | 37762551 | PubTator, text mining | PubMed |
| Washed Microbiota Transplantation Improves Patients with Overweight by the Gut Microbiota and Sphingolipid Metabolism. | Biomedicines | 2023 | 37760856 | PubTator, text mining | PubMed |
| Structural insights into the activation of ataxia-telangiectasia mutated by oxidative stress. | Sci Adv | 2023 | 37756394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23049/papers?page=12